Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target?

Senoner T, Dichtl W. · 2019

Read Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target? by Senoner T, Dichtl W. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6769522.txt.

Introduction

Senoner and Dichtl ask whether oxidative stress in cardiovascular disease is still a treatment target. Heart and vessel diseases kill more people than any other cause. Excess reactive oxygen species, or ROS, are one suspected common root. Cells need a small basal level of ROS to work. Too much damages DNA, fats, and proteins and kills cells.

High ROS cut nitric oxide supply, tightening vessels and raising blood pressure. They disturb calcium handling in heart muscle, causing rhythm problems. They also drive plaque growth in arteries. Mouse work pinned a key role on one ROS source, NOX2. The review closes with diets and nutraceuticals that might help restore balance.

Catalog record

CREATORSenoner T, Dichtl W.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE98 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6769522

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target? By Thomas Senoner, Wolfgang Dichtl Published in: Nutrients DOI: 10.3390/nu11092090 ABSTRACT Abstract Cardiovascular diseases (CVD) are complex entities with heterogenous pathophysiologic mechanisms and increased oxidative stress has been viewed as one of the potential common etiologies. A fine balance between the presence of reactive oxygen species (ROS) and antioxidants is essential for the proper normal functioning of the cell. A basal concentration of ROS is indispensable for the manifestation of cellular functions, whereas excessive levels of ROS cause damage to cellular macromolecules such as DNA, lipids and proteins, eventually leading to necrosis and apoptotic cell death. CVD is the main cause of death worldwide with several conditions being affected by oxidative stress. Increased ROS lead to decreased nitric oxide availability and vasoconstriction, promoting arterial hypertension. ROS also negatively influence myocardial calcium handling, causing arrhythmia, and augment cardiac remodeling by inducing hypertrophic signaling and apoptosis. Finally, ROS have also been shown to promote atherosclerotic plaque formation. This review aims at giving an introduction into oxidative stress in CVD, with special focus on endothelial dysfunction, and then examining in detail the role of oxidative stress in the most prevalent of these diseases. Finally, potential nutraceuticals and diets that might be beneficial in diminishing the burden of oxidative stress in CVD are presented. Keywords: antioxidants, oxidative stress, nutraceuticals, cardiovascular diseases 1. INTRODUCTION A variety of cardiovascular diseases have been shown to be associated, at least partially, with an excess production of reactive oxygen species (ROS) [1,2,3,4]. ROS constitute both oxygen free radicals, such as superoxide, hydroxyl radicals, and peroxyl radicals, as well as non-radicals, such as hydrogen peroxide, hypochlorous acid, and ozone [5]. In most cell types, mitochondria are the main drivers of intracellular oxidant production, while other relevant sources are nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (summarized as the NOX family of enzymes). Apart from that, numerous other enzymes such as xanthine oxidase, nitric oxide synthase, cyclooxygenases, cytochrome P450 enzymes, and lipoxygenases as well as other cell organelles, like the peroxisome and endoplasmic reticulum, contribute to intracellular ROS production [6]. Proteins, lipids and DNA are the primary cellular structures affected by ROS and reactive nitrogen species (RNS). The generation of molecular oxygen in the form of ROS is a natural part of aerobic life. Indeed, basal levels of ROS are essential for the manifestation of various cellular functions, such as signal transduction pathways, defense against invading microorganisms, gene expression and the promotion of growth or death [7]. In spite of the crucial relevance of redox reactions, dysregulation of oxidant signaling may cause or accelerate a host of pathological conditions, such as the rate of aging. However, the body is equipped with protective measures against ROS via enzymatic (e.g., superoxide dismutase (SOD), catalase (CAT), peroxiredoxin (Prx) and glutathione peroxidase (GSH-Px)) as well as non-enzymatic compounds (e.g., tocopherol/vitamin E, beta-carotene, ascorbate, glutathione (GSH), and nicotinamide (NAM)) [8]. Newer research tools allow the investigation of redox signaling pathways in adequate chemical detail, and it has become clear that redox processes are as important in biology as phosphorylation-dephosphorylation reactions, or central mechanisms responsible for controlling the genome and epigenome, such as acetylation–deacetylation and methylation–demethylation [9]. However, the analysis of redox systems is challenging due to the substantial subcellular differences in redox potential and the short lifespan of ROS. The discovery of numerous biomarkers of oxidative stress has facilitated the measurement of ROS; however, their clinical use still needs to be validated given the vast diversity in oxidative stress between different diseases. Genomics, epigenomics, and exposomics along with methodologies for redox imaging, redox proteomics, and redox metabolomics, will improve our understanding of health and disease processes within entire biological systems. Furthermore, the emerging big data and artificial intelligence era will provide us with new opportunities for the development of oxidative stress knowledge bases and paves the way for a more personalized redox medicine [9]. In 2016, ≈17.6 million deaths were attributed to cardiovascular diseases (CVD) globally, which amounted to an increase of 14.5% from 2006 [10]. CVD is currently the leading cause of death, and it claims more lives each year than cancer and chronic lung disease combined. Coronary heart disease (CHD) represents the most common CVD [10]. In the coming decades, with an aging population and increased incidence of obesity and diabetes, the burden and medical costs of CVD are anticipated to significantly increase worldwide. Although significant efforts have been made to enlighten pathophysiologic mechanisms governing the initiation and progression of CVD, still much work has to be done [11,12,13]. As such, a better understanding of the biomolecular mechanisms and their clinical consequences is urgently needed to reduce the burden of CVD, and this poses a serious challenge in medicine. This review will exemplify the role of oxidative stress in CVD, first enlightening the pathomechanisms underlying oxidative stress and CVD with a special focus on a main contributor of disease, namely endothelial dysfunction. Afterwards, it delves into oxidative stress and inflammation in the most prevalent of these diseases and will finally conclude with a discussion about the effects of diet and nutraceuticals on oxidative stress in CVD. 2. ENDOTHELIAL DYSFUNCTION IN CARDIOVASCULAR DISEASE The endothelium is a highly active monolayer that plays important roles in modulating vascular tone, cellular adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall inflammation. This is achieved by the production and release of several endothelium-derived relaxing factors, including vasodilator prostaglandins, nitric oxide (NO), and endothelium-dependent hyperpolarization factors, as well as endothelium-derived contracting factors. These vasoactive molecules that relax or constrict the vessel play a direct role in the balance of tissue oxygen supply, long-term organ perfusion, remodeling of vascular structures, and metabolic demand by regulation of vessel tone and diameter [14,15]. Endothelial cells dispose of an enzyme to fight vascular disease, namely endothelial nitric oxide synthase (eNOS), which generates the vasoprotective molecule NO. This molecule diffuses to the vascular smooth muscle cells, activates soluble guanylyl cyclase and increases cyclic guanosine monophosphate (cGMP) [16]. NO can also inhibit leukocyte adhesion to the vessel wall which represents an early event in the development of atherosclerosis; therefore, NO may protect against the onset of atherogenesis. Furthermore, NO is also involved in the inhibition of platelet aggregation and adhesion, both of which protect smooth muscle cells from exposure to platelet-derived growth factors. These mechanisms can lead to fibrous plaque formation; therefore, NO also prevents a later step in atherogenesis. NO suppresses key processes in vascular lesion formation and thus probably represents the most important antiatherogenic defense principle in the vasculature [16]. The pathomechanisms of endothelial dysfunction involve a diminished production and/or availability of NO, and a disproportion between the endothelium-derived vasodilators and vasoconstrictors. Several traditional cardiovascular risk factors are associated with alteration in endothelial function such as smoking, sedentary and incorrect lifestyle, aging, hypercholesterolemia, arterial hypertension, hyperglycemia, and a family history of premature atherosclerotic disease (Figure 1) [17,18]. This leads to chronic inflammation, resulting in an increase in vasoconstrictor and prothrombotic products and diminished antithrombotic factors, in addition to abnormal vasoreactivity, all of which elevate the risk of cardiovascular events. Indeed, endothelial dysfunction has also been linked with obesity, elevated C-reactive protein, and chronic systemic infection [18]. Oxidative stress and inflammation are the main drivers of

Read the complete text